by Niigata University Credit: Pixabay/CC0 Public Domain Researchers from Niigata University and Kyoto Prefectural University have revealed that small vesicles, around 100 nm in size, released by intestinal bacteria induce immune activation and progression of liver cirrhosis, as well as a reduction of serum albumin levels, subsequently leading to edema and ascites. The research is published in the...
by Elana Gotkine HealthDay Reporter Opioids are frequently prescribed to patients with cirrhosis, often without a pain diagnosis, according to a research letter published online Dec. 8 in Clinical Gastroenterology and Hepatology. Anna H. Lee, M.D., from the David Geffen School of Medicine at the University of California in Los Angeles, and colleagues conducted a retrospective study...
AMERICAN GASTROENTEROLOGICAL ASSOCIATION Bethesda, MD (November 3, 2021) — Patients with cirrhosis, or permanent liver damage, are at higher risk for coagulation disorders, which impact your body’s ability to control blood clotting. This puts cirrhosis patients at increased risk of morbidity and mortality when undergoing diagnostic or therapeutic invasive procedures. The American Gastroenterological Association (AGA) has...
